Language Selector:

Lungpacer Medical, Inc. Announces Publication of First-In-Human (FIH) Study Results in Critical Care Medicine

BURNABY, British Columbia, July 2017

Lungpacer Medical, Inc., a medical device company developing an intravenous catheter-based phrenic-nerve-pacing system, announced today that the FIH study results of the PACER study have been published in the journal Critical Care Medicine. This First-in-Human case series demonstrates that the diaphragm can contribute significantly to the work of breathing when activated by a catheter-based, transvenous pacing system. Phrenic nerve stimulation-induced negative-pressure ventilation may have advantages over positive-pressure mechanical ventilation. Diaphragm Activation in Ventilated Patients Using a Novel Transvenous Phrenic Nerve Pacing Catheter was published in Critical Care Medicine, S. Reynolds et al.  Crit Care Med. 2017; 45(7):e691-e694. doi: 10.1097/CCM.0000000000002366